Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지

Factors Related to Substantial Pain in Terminally Ill Cancer Patients

  • Suh, Sang-Yeon (Department of Medicine, Dongguk University) ;
  • Song, Kyung-Po (Department of Family Medicine, Dongguk University Ilsan Hospital) ;
  • Choi, Sung-Eun (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ahn, Hong-Yup (Department of Statistics, Dongguk University) ;
  • Choi, Youn-Seon (Department of Family Medicine, Korea University Guro Hospital) ;
  • Shim, Jae-Yong (Department of Family Medicine, Gangnam Severance Hospital, Yonsei University Health System)
  • Received : 2011.07.20
  • Accepted : 2011.08.05
  • Published : 2011.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Pain is the most common and influential symptom in cancer patients. Few studies concerning pain intensity in the terminally ill cancer patients have been done. This study aimed to identify factors related with more than moderate pain. Methods: This study used secondary data of 162 terminal cancer inpatients at the palliative ward of six training hospitals in Korea. Physician-assessed pain assessment was by 10 point numeric rating scale. Substantial pain was defined more than moderate intensity by the Korean National Guideline for cancer pain. The Korean version of the MD Anderson Symptom Inventory was self-administered to assess symptoms. Survival prediction was estimated by the attending physicians at the time of admission. Results: Less than six weeks of predicted survival and more than numeric rating of six for worst drowsiness in the previous 24 h were significantly related to substantial pain (P=0.012 and P=0.046, respectively). The dose of opioid analgesics was positively related to substantial pain (P=0.004). Conclusion: Factors positively related to substantial pain were less than six weeks of predicted survival and considerable drowsiness. Careful monitoring and active preparation for pain are required in terminal cancer patients having those factors.

목적: 암환자에게 통증은 가장 흔하고 영향이 큰 증상이다. 그러나 말기암환자에서 통증 강도에 대한 연구는 부족하였다. 본 연구는 중등도 이상의 통증과 연관된 요인을 밝히고자 한다. 방법: 우리나라 완화의료 기관 6곳의 입원 병동을 대상으로 말기 암 환자 162명 자료를 사용하였다. 통증은 담당의가 10점 만점 숫자통증등급으로 측정하였다. 중등도 이상의 통증은 보건복지부 지침의 정의에 따랐다. 증상 평가에는 MD Anderson 증상 평가조사지 한국어본을 활용하였다. 생존기간 예측은 입원 당시 담당 전문의가 하였다. 결과: 예측 생존 기간이 6주 미만인 경우와 지난 24시간 졸린 정도가 6점 이상인 경우가 중등도 이상의 통증과 유의하게 연관되었다(각각 P=0.012, P=0.046). 마약성 진통제 투여량도 중등도 이상의 통증에 비례하였다(P=0.004). 결론: 중등도 이상의 통증과 유의하게 연관된 요인은 예측 생존 기간이 6주 미만인 것과 상당한 졸림이었다. 이러한 요인을 나타내는 말기 암 환자에서 주의 깊은 통증의 감시와 적극적인 대비가 필요하다.

Keywords

References

  1. Modonesi C, Scarpi E, Maltoni M, Derni S, Fabbri L, Martini F, et al. Impact of palliative care unit admission on symptom control evaluated by the edmonton symptom assessment system. J Pain Symptom Manage 2005;30:367-73. https://doi.org/10.1016/j.jpainsymman.2005.04.007
  2. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437-49. https://doi.org/10.1093/annonc/mdm056
  3. Vallerand AH, Templin T, Hasenau SM, Riley-Doucet C. Factors that affect functional status in patients with cancer-related pain. Pain 2007;132:82-90. https://doi.org/10.1016/j.pain.2007.01.029
  4. WHO: WHO's pain ladder [Internet]. Geneva: World Health Organization; c2011. Available from: http://www.who.int/cancer/ palliative/painladder/en/.
  5. Yun YH, Heo DS, Lee IG, Jeong HS, Kim HJ, Kim SY, et al. Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manage 2003;25:430-7. https://doi.org/10.1016/S0885-3924(03)00103-9
  6. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain 1986;27:117-26. https://doi.org/10.1016/0304-3959(86)90228-9
  7. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-84. https://doi.org/10.1016/0304-3959(94)00178-H
  8. National Cancer Information Center (NCIC), Chapter 2. Pharmacotherapy of cancer pain. In: NCIC. Cancer Pain Management Guideline. Version 3.1. Ministry for health, welfare and family affairs;2008. p. 15.
  9. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, et al. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology 2004;66:439-44. https://doi.org/10.1159/000079497
  10. Suh SY, Choi YS, Shim JY, Kim YS, Yeom CH, Kim D, et al. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer 2009.
  11. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, et al. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage 2006;31:345-52. https://doi.org/10.1016/j.jpainsymman.2005.07.013
  12. Doyle D, Hanks GW, MacDonald N. Oxford textbook of palliative medicine. 2th ed. New York:Oxford University Press; 1998.
  13. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005;23:6240-8. https://doi.org/10.1200/JCO.2005.06.866
  14. Halabi S, Vogelzang NJ, Kornblith AB, Ou SS, Kantoff PW, Dawson NA, et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol 2008;26:2544-9. https://doi.org/10.1200/JCO.2007.15.0367
  15. Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 1999;86:170-6. https://doi.org/10.1002/(SICI)1097-0142(19990701)86:1<170::AID-CNCR23>3.0.CO;2-S
  16. Clark J, Cunningham M, McMillan S, Vena C, Parker K. Sleep-wake disturbances in people with cancer part II: evaluating the evidence for clinical decision making. Oncol Nurs Forum 2004;31:747-71. https://doi.org/10.1188/04.ONF.747-771
  17. Mystakidou K, Parpa E, Tsilika E, Gennatas C, Galanos A, Vlahos L. How is sleep quality affected by the psychological and symptom distress of advanced cancer patients? Palliat Med 2009; 23:46-53. https://doi.org/10.1177/0269216308098088
  18. McMillan SC, Tofthagen C, Morgan MA. Relationships among pain, sleep disturbances, and depressive symptoms in outpatients from a comprehensive cancer center. Oncol Nurs Forum 2008;35:603-11. https://doi.org/10.1188/08.ONF.603-611
  19. Rumble ME, Keefe FJ, Edinger JD, Porter LS, Garst JL. A pilot study investigating the utility of the cognitive-behavioral model of insomnia in early-stage lung cancer patients. J Pain Symptom Manage 2005;30:160-9. https://doi.org/10.1016/j.jpainsymman.2005.02.013
  20. Sayar K, Arikan M, Yontem T. Sleep quality in chronic pain patients. Can J Psychiatry 2002;47:844-8. https://doi.org/10.1177/070674370204700905
  21. Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, et al. A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 2007;75:37-44. https://doi.org/10.1016/j.biopsycho.2006.11.002
  22. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V, et al. The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep 2007;30:737-42. https://doi.org/10.1093/sleep/30.6.737
  23. Kautio AL, Haanpaa M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 2008;35:31-9. https://doi.org/10.1016/j.jpainsymman.2007.02.043
  24. Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, et al. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 2008; 62:75-83. https://doi.org/10.1111/j.1440-1819.2007.01778.x
  25. Manfredi PL, Gonzales GR. Symptomatic uses of caffeine in patients with cancer. J Palliat Care 2003;19:63-5.
  26. Mercadante S, Serretta R, Casuccio A. Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study. J Pain Symptom Manage 2001;21:369-72. https://doi.org/10.1016/S0885-3924(01)00249-4
  27. Bruera E, Watanabe S. Psychostimulants as adjuvant analgesics. J Pain Symptom Manage 1994;9:412-5. https://doi.org/10.1016/0885-3924(94)90179-1
  28. Spiegel D, Sands S, Koopman C. Pain and depression in patients with cancer. Cancer 1994;74:2570-8. https://doi.org/10.1002/1097-0142(19941101)74:9<2570::AID-CNCR2820740927>3.0.CO;2-3
  29. Mystakidou K, Tsilika E, Parpa E, Pathiaki M, Patiraki E, Galanos A, et al. Exploring the relationships between depression, hopelessness, cognitive status, pain, and spirituality in patients with advanced cancer. Arch Psychiatr Nurs 2007;21:150-61. https://doi.org/10.1016/j.apnu.2007.02.002
  30. Echteld MA, van Zuylen L, Bannink M, Witkamp E, Van der Rijt CC. Changes in and correlates of individual quality of life in advanced cancer patients admitted to an academic unit for palliative care. Palliat Med 2007;21:199-205. https://doi.org/10.1177/1352458507077404